- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05812053
Comparative Evaluation of Eggshell Powder in Primary Teeth Pulpotomy
December 5, 2023 updated by: Shaimaa Shaban Mohamed El-desouky, Tanta University
Comparative Evaluation of Eggshell Powder Versus Biodentine in Primary Teeth Pulpotomy: Clinical And Radiographic Study
To assess & compare clinical & radiographic effects of Tea Tree Oil- Eggshell Powder and Biodentine as pulpotomy agents in primary teeth.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Pulpotomy is the most widely accepted technique for treating primary teeth with deep carious lesion, pulp exposure during the operatory process or after a traumatic pulp exposure.
Mineral trioxide aggregate (MTA) is one such material that has shown tremendous potential for regeneration.
Biodentine™ (hydraulic silicate cement) is a novel dental material with high mechanical characteristics as well as superior biocompatibility and bioactive behaviour.
Nowadays, chicken eggshell powder (CESP) (a natural calcium-rich source) is achieving wide acceptance in the medical and dental fields.
Tea tree oil is the essential oil extracted from the Australian native Melaleuca alternifolia or the tea tree.
To date, there is insufficient evidence to properly evaluate Tea Tree Oil- Eggshell Powder as a pulpotomy agent in primary teeth; thus, the current study aimed to assess and compare clinical and radiographical success of Tea Tree Oil- Eggshell Powder and Biodentine as pulpotomy agents in primary teeth.
Study Type
Interventional
Enrollment (Estimated)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: shaimaa eldesouky, lecturer
- Phone Number: tanta +201008994242
- Email: shaimaaeldesouky@dent.tanta.edu.eg
Study Locations
-
-
Gharbia
-
Tanta, Gharbia, Egypt, 6624033
- Recruiting
- Tanta University
-
Contact:
- Shaimaa eldesouky, PhD
- Phone Number: +201008994242
- Email: shiamaaeldesouky@dent.tanta.edu.eg
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Restorable primary molars with deep carious lesions.
- Absence of gingival swelling or sinus tract.
- Absence of spontaneous pain
- Absence of pain on percussion.
- Absence of discontinuity of lamina dura
- Absence of internal root resorption.
- Absence of external root resorption.
- Absence of inter-radicular or periapical bone destruction (radiolucency).
Exclusion Criteria:
- presence of spontaneous pain
- presence of gingival swelling or sinus tract
- presence of internal or external root resorption
- pain on percussion.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: group 1: Tea Tree Oil- Eggshell Powder
30 primary molars will be treated with Eggshell Powder freshly mixed with Tea Tree Oil till reach suitable consistency (1:1 ratio by volume) to cover pulp stumps
|
Teeth will be anesthetized then Rubber dam and high suction will be used in pulpotomy procedure.
Cavity outline was performed by sterile #330 high speed bur using water spray.
Caries was removed by large spoon excavator.
When pulpal exposure occurred, the roof of pulp chamber removed by low speed round bur.
Haemostasis was obtained by applying pressure with moist cotton pellet with saline.
Then the test materials was applied.
after that, pulp stumps of all molars in each group will be dressed using Intermediate restorative material then the tooth will be restored with a preformed stainless steel crown
a post-operative CBCT image will be taken immediately after completing the procedure with fixed exposure parameters (120 Kv, 5mA, and 0.125mm voxel size) using the smallest field of view (8D, 8Hcm) also, after 6 and 12 months follow-up periods.
|
Experimental: group II: biodentine
30 primary molars will be treated with biodentine to cover pulp stumps
|
Teeth will be anesthetized then Rubber dam and high suction will be used in pulpotomy procedure.
Cavity outline was performed by sterile #330 high speed bur using water spray.
Caries was removed by large spoon excavator.
When pulpal exposure occurred, the roof of pulp chamber removed by low speed round bur.
Haemostasis was obtained by applying pressure with moist cotton pellet with saline.
Then the test materials was applied.
after that, pulp stumps of all molars in each group will be dressed using Intermediate restorative material then the tooth will be restored with a preformed stainless steel crown
a post-operative CBCT image will be taken immediately after completing the procedure with fixed exposure parameters (120 Kv, 5mA, and 0.125mm voxel size) using the smallest field of view (8D, 8Hcm) also, after 6 and 12 months follow-up periods.
|
Active Comparator: group III: mineral tri-oxide aggregate (MTA)
30 primary molars will be treated with MTA to cover pulp stumps
|
Teeth will be anesthetized then Rubber dam and high suction will be used in pulpotomy procedure.
Cavity outline was performed by sterile #330 high speed bur using water spray.
Caries was removed by large spoon excavator.
When pulpal exposure occurred, the roof of pulp chamber removed by low speed round bur.
Haemostasis was obtained by applying pressure with moist cotton pellet with saline.
Then the test materials was applied.
after that, pulp stumps of all molars in each group will be dressed using Intermediate restorative material then the tooth will be restored with a preformed stainless steel crown
a post-operative CBCT image will be taken immediately after completing the procedure with fixed exposure parameters (120 Kv, 5mA, and 0.125mm voxel size) using the smallest field of view (8D, 8Hcm) also, after 6 and 12 months follow-up periods.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
absence of pain
Time Frame: up to 12 months
|
Measuring Method: Verbal Question to Patient /Parents Measuring Unite: score 0 for absence of pain and score 1 for presence of pain
|
up to 12 months
|
absence of fistula
Time Frame: up to 12 months
|
Measuring Method: Visual examination by operator Measuring Unite: score 0 for absence of swelling and score 1 for presence of swelling
|
up to 12 months
|
Tenderness to percussion
Time Frame: Up to 12 month
|
Measuring Method: Percussion test Measuring Unite: Binary (+/-)
|
Up to 12 month
|
Furcation radiolucency
Time Frame: 6 months
|
Measuring Method: cone beam computed tomography (CBCT) for assessment of radio-density of bone at the furcation area Measuring Unite: Binary (+/-)
|
6 months
|
Furcation radiolucency
Time Frame: 12 months
|
Measuring Method: cone beam computed tomography (CBCT) for assessment of radio-density of bone at the furcation area Measuring Unite: Binary (+/-)
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Nowicka A, Lipski M, Parafiniuk M, Sporniak-Tutak K, Lichota D, Kosierkiewicz A, Kaczmarek W, Buczkowska-Radlinska J. Response of human dental pulp capped with biodentine and mineral trioxide aggregate. J Endod. 2013 Jun;39(6):743-7. doi: 10.1016/j.joen.2013.01.005. Epub 2013 Apr 10.
- Celik BN, Mutluay MS, Arikan V, Sari S. The evaluation of MTA and Biodentine as a pulpotomy materials for carious exposures in primary teeth. Clin Oral Investig. 2019 Feb;23(2):661-666. doi: 10.1007/s00784-018-2472-4. Epub 2018 May 10.
- Siva Rama Krishna D, Siddharthan A, Seshadri SK, Sampath Kumar TS. A novel route for synthesis of nanocrystalline hydroxyapatite from eggshell waste. J Mater Sci Mater Med. 2007 Sep;18(9):1735-43. doi: 10.1007/s10856-007-3069-7. Epub 2007 May 5.
- Kattimani VS, Chakravarthi PS, Kanumuru NR, Subbarao VV, Sidharthan A, Kumar TS, Prasad LK. Eggshell derived hydroxyapatite as bone graft substitute in the healing of maxillary cystic bone defects: a preliminary report. J Int Oral Health. 2014 Jun;6(3):15-9. Epub 2014 Jun 26.
- Hart PH, Brand C, Carson CF, Riley TV, Prager RH, Finlay-Jones JJ. Terpinen-4-ol, the main component of the essential oil of Melaleuca alternifolia (tea tree oil), suppresses inflammatory mediator production by activated human monocytes. Inflamm Res. 2000 Nov;49(11):619-26. doi: 10.1007/s000110050639.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2023
Primary Completion (Estimated)
March 1, 2024
Study Completion (Estimated)
April 1, 2024
Study Registration Dates
First Submitted
March 21, 2023
First Submitted That Met QC Criteria
April 1, 2023
First Posted (Actual)
April 13, 2023
Study Record Updates
Last Update Posted (Estimated)
December 7, 2023
Last Update Submitted That Met QC Criteria
December 5, 2023
Last Verified
December 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- #R-PED-9-20-2
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pulp Exposure, Dental
-
Cairo UniversityCompletedDental Pulp Capping | Pulp Exposure, DentalEgypt
-
Ahmad ElheenyRecruiting
-
Istanbul Medipol University HospitalEnrolling by invitationPulp Exposure, DentalTurkey
-
TIJEN PAMIRActive, not recruitingDental Caries, Dental Pulp Exposure
-
National University Health System, SingaporeCompletedPulpitis | Pulp Exposure, Dental | Pulp and Periapical Tissue Disease
-
Gihan M Abuelniel ,PhDCairo UniversityCompletedPulp Exposure, DentalEgypt
-
burcu gözeticiIstanbul Medipol University HospitalActive, not recruitingDental Caries | Deep Caries | Pulp Exposure, DentalTurkey
-
Cairo UniversityActive, not recruitingDeep Caries | Pulp Exposure, DentalEgypt
-
Oregon Health and Science UniversityNational Institute of Dental and Craniofacial Research (NIDCR); University...Completed
Clinical Trials on pulpotomy
-
University GhentCompleted
-
Cairo UniversityNot yet recruiting
-
Postgraduate Institute of Dental Sciences RohtakRecruitingPulpitis - IrreversibleIndia
-
Cairo UniversityUnknownSymptomatic Irreversible Pulpitis
-
British University In EgyptAin Shams UniversityRecruiting
-
University of Alabama at BirminghamNot yet recruitingIrreversible PulpitisUnited States
-
Jordan University of Science and TechnologyActive, not recruiting
-
Universitat Internacional de CatalunyaUnknownEvaluate the Effects of MEDCEM PC and MTA in Pulpotomies of Primary Molars.Spain
-
National University Health System, SingaporeCompletedPulpitis | Pulp Exposure, Dental | Pulp and Periapical Tissue Disease